AwesomeCapital

It’s a perfect case of the enemy of my enemy is my friend. A potentially dangerous bacteria appears to target malignant cells and could...

Hello. I’m Dr Charles Vega, and I am a clinical professor of family medicine at the University of California at Irvine. Welcome to Medscap...

Older adults who experienced a first major osteoporotic fracture had an increased risk for having an additional subsequent fracture, with ...

Biotech shares saw further momentum last week, following up on the gains of the previous two weeks. Will the momentum continue in the up...

Sanofi said it would begin global phase-3 clinical trials to compare Hanmi Pharmaceuticals new obesity and diabetes treatment Efpeglenatid...

Children with severe allergies who need to carry life-saving medication are being forced to rely on out-of-date EpiPens due to a global sh...

Coversin, a first-in-class combined complement C5 and leukotriene B4 (LTB4) inhibitor, is currently being developed to treat four orphan d...